Fabio Giannessi

Selective Reversible Inhibition of Liver Carnitine Palmitoyl-Transferase 1 by Teglicar Reduces Gluconeogenesis and Improves Glucose Homeostasis

Roberto Conti, Edoardo Mannucci, Pompeo Pessotto et al. · Diabetes · 2011 · 90 citations · Full text

Isolation and pharmacological activities of the Tecoma stans alkaloids

Luca Costantino, Laura Raimondi, R. Pirisino et al. · Il Farmaco · 2003 · 86 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +7

Discovery of a Long-Chain Carbamoyl Aminocarnitine Derivative, a Reversible Carnitine Palmitoyltransferase Inhibitor with Antiketotic and Antidiabetic Activity

Fabio Giannessi, Pompeo Pessotto, Emanuela Tassoni et al. · Journal of Medicinal Chemistry · 2002 · 71 citations · Full text

Medicinal Chemistry, Ureidic Compound 17, Pharmacological Study +14

In Vivo Imaging Reveals Selective Peroxisome Proliferator Activated Receptor Modulator Activity of the Synthetic Ligand 3-(1-(4-Chlorobenzyl)-3-t-butylthio-5-isopropylindol-2-yl)-2,2-dimethylpropanoic acid (MK-886)

Andrea Biserni, Fabio Giannessi, Anna Floriana Sciarroni et al. · Molecular Pharmacology · 2008 · 35 citations

Reversible Carnitine Palmitoyltransferase Inhibitors with Broad Chemical Diversity as Potential Antidiabetic Agents

Fabio Giannessi, P. Chiodi, Mauro Marzi et al. · Journal of Medicinal Chemistry · 2001 · 33 citations · Full text

Experimental Pharmacology, Insulin Signaling, Metabolic Syndrome +17